相关实验视频
Updated: Jun 21, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
TLR激动剂修改NK细胞活化并增加其在急性淋巴细胞白血病中的细胞毒性
Janet Gallardo-Zapata1,2, Erandi Pérez-Figueroa1, Víctor Olivar-López3
1Immunology and Proteomics Research Laboratory, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
用R848和ODN2006等连接体激活托尔类受体 (TLR),可以增强急性淋巴细胞白血病中自然杀手 (NK) 细胞的抗瘤活性. 这种免疫疗法策略增强NK细胞功能和对癌细胞的细胞毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 具有天生的免疫力.
背景情况:
- 自然杀手 (NK) 细胞对抗感染和瘤的天生的免疫力至关重要.
- 血液癌症,如急性淋巴细胞白血病 (ALL),通常会损害NK细胞的功能.
- 恢复NK细胞抗瘤活性是关键的治疗目标.
研究的目的:
- 研究激活内体托尔类受体 (TLRs) 的潜力,以恢复儿童ALL的NK细胞抗瘤活性.
- 评估特定TLR连体对NK细胞激活和功能的影响.
主要方法:
- 从患有ALL的儿童中分离出NK细胞.
- 用TLR连体刺激NK细胞:多I:C (TLR3),伊米基莫德 (TLR7),R848 (TLR8) 和ODN2006 (TLR9).
- 评估NK细胞激活标记物 (IFN-γ,CD107a,NKG2D,NKp44),细胞毒性和细胞因子释放的变化.
主要成果:
- 聚I:C和伊米基莫德增强了NK细胞的激活和关键标记物的表达.
- R848激活了免疫调节NK细胞并增加了细胞因子分泌.
- ODN2006增强了细胞毒性NK细胞标记物,并显著改善了针对白血病细胞的细胞毒性.
- R848和ODN 2006显示出显著的抗瘤作用.
结论:
- 在ALL的背景下,TLR刺激有效地增强NK细胞的激活和功能.
- TLR8 (R848) 和TLR9 (ODN2006) 连接体显示出作为免疫治疗剂增强NK细胞介导的抗瘤反应的前景.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...